15 Aug
|
Boehringer Ingelheim
|
Sydney
15 Aug
Boehringer Ingelheim
Sydney
Boehringer Ingelheim is looking for a professional to lead the launch and commercialization of Survodutide, transforming the future of obesity and metabolic health.
This opportunity entails shaping brand strategy for a pre-launch asset, with responsibilities including developing customer plans, defining value propositions, and ensuring regulatory compliance.The ideal candidate should possess over five years in pharmaceutical brand management and a robust record of success in pre-launch or launch settings.
Join us to make a significant impact on patient outcomes and lead a high-performing brand team.
#J-*****-Ljbffr
📌 Metabolic Health Brand Lead - Launch & Growth (Sydney)
🏢 Boehringer Ingelheim
📍 Sydney